-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RU6oVRRSrmXLJhaF//GqG9zq4BLvEspTGiESvWYOS/6Y4y7G2X+oV4DnqdBbOPNq F9Sa3CUYXwsTrHCjJ47ECg== 0001144204-10-059584.txt : 20101112 0001144204-10-059584.hdr.sgml : 20101111 20101112130426 ACCESSION NUMBER: 0001144204-10-059584 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101111 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20101112 DATE AS OF CHANGE: 20101112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIO BRIDGE SCIENCE INC CENTRAL INDEX KEY: 0001309304 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201802936 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-51497 FILM NUMBER: 101184964 BUSINESS ADDRESS: STREET 1: 1211 WEST 22ND STREET STREET 2: SUITE 615 CITY: OAK BROOK STATE: IL ZIP: 60523 BUSINESS PHONE: 630-928-0869 MAIL ADDRESS: STREET 1: 1211 WEST 22ND STREET STREET 2: SUITE 615 CITY: OAK BROOK STATE: IL ZIP: 60523 8-K 1 v202232_8k.htm Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
 
Date of report (Date of earliest event reported):  November 11, 2010
 
 
BIO-BRIDGE SCIENCE, INC.
(Exact name of registrant as specified in its charter)
     
DELAWARE
000-51497
20-1802936
(State or other jurisdiction
(Commission File Number)
(I.R.S. Employer
of incorporation or organization)
 
Identification No.)
 
1801 South Meyers Road, Suite 220, Oakbrook Terrace, IL
60181
(Address of Principal Executive Offices)
(Zip Code)
 
 
630-613-9687
(Registrant’s telephone number, including area code)


N/A
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    
 
     
Item 5.02.
  
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
    (b) On November 11, 2010, Chuen Huei (Kevin) Lee resigned, effective the same day, as Chief Financial Officer of Bio-Bridge Science, Inc.  Mr. Lee will remain a consultant to the Company.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
Bio-Bridge Science, Inc.
  
       
Date:  November 12, 2010
By:
/s/ Dr. Liang Qiao  
    Name: Dr. Liang Qiao  
       
       
 
 
 -----END PRIVACY-ENHANCED MESSAGE-----